CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy

The benefits of CAR-T therapy could be expanded to the treatment of solid tumors through the use of derived autologous αβ T cell, but clinical trials of CAR-T therapy for patients with solid tumors have so far been disappointing. CAR-T therapy also faces hurdles due to the time and cost intensive pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yizheng, Wang, Linan, Seo, Naohiro, Okumura, Satoshi, Hayashi, Tae, Akahori, Yasushi, Fujiwara, Hiroshi, Amaishi, Yasunori, Okamoto, Sachiko, Mineno, Junichi, Tanaka, Yoshimasa, Kato, Takuma, Shiku, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341429/
https://www.ncbi.nlm.nih.gov/pubmed/37446055
http://dx.doi.org/10.3390/ijms241310873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341429/
https://www.ncbi.nlm.nih.gov/pubmed/37446055
http://dx.doi.org/10.3390/ijms241310873

Ejemplares similares